Treatment efficacy and glucose variability control of exenatide versus biphasic insulin aspart 30 in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicenter, randomized, open-label, parallel study

被引：0
|
作者：
Liu, Xiangyang [1 ]
Ji, Qiuhe [1 ]
Yang, Wenjuan [2 ]
Liu, Jianrong [3 ]
Gao, Xiling [4 ]
He, Qingzhen [5 ]
Ma, Kaiyan [6 ]
Tian, Zhufang [7 ]
Xie, Xuan [8 ]
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian, Shaanxi, Peoples R China
[2] Shaanxi Aerosp Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[3] Xian Chang An Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[4] Yanan Peoples Hosp, Dept Endocrinol, Yanan, Shannxi Provinc, Peoples R China
[5] Xian Gaoxin Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[6] Shangluo Cent Hosp, Dept Endocrinol, Shangluo, Shannxi Provinc, Peoples R China
[7] Xian Cent Hosp, Dept Endocrinol, Xian, Shannxi Provinc, Peoples R China
[8] Xi An Jiao Tong Univ, Dept Endocrinol, Affiliated Hosp 2, Xian, Shannxi Provinc, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1053987
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Patients with type 2 diabetes mellitus poorly controlled on biphasic human insulin alone show improved glucose control with biphasic insulin aspart 30
    Shestakova, Marina V.
    Lebedev, Nikolay
    Bech, Ole M.
    DIABETES, 2008, 57 : A560 - A560
  • [32] 28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes
    Kadowaki, Takashi
    Nishida, Tomoyuki
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (03) : 103 - 110
  • [33] Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus
    Niskanen, L
    Jensen, LE
    Råstam, J
    Nygaard-Pedersen, L
    Erichsen, K
    Vora, JE
    CLINICAL THERAPEUTICS, 2004, 26 (04) : 531 - 540
  • [34] A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus
    Quan, Huibiao
    Zhang, Huachuan
    Wei, Weiping
    Fang, Tuanyu
    Chen, Daoxiong
    Chen, Kaining
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 3279 - 3287
  • [35] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
    Du, J.
    Liang, L.
    Fang, H.
    Xu, F.
    Li, W.
    Shen, L.
    Mu, Y.
    DIABETOLOGIA, 2016, 59 : S372 - S372
  • [36] Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial
    Yao, Jun
    Guo, Xiaohui
    Sun, Li
    Han, Ping
    Lv, Xiaofeng
    Zhang, Xiuzhen
    Mo, Zhaohui
    Yang, Wenying
    Zhang, Lihui
    Wang, Zhanjian
    Zhu, Lvyun
    Li, Quanmin
    Yang, Tao
    Wang, Wenbo
    Xue, Yaoming
    Shi, Yongquan
    Lu, Juming
    Peng, Yongde
    Zhang, Fan
    Yan, Dewen
    Wang, Damei
    Yu, Xuefeng
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1797 - 1806
  • [37] Efficacy of glyburide/metformin tablets versus metformin plus rosiglitazone in patients with Type 2 diabetes inadequately controlled with metformin monotherapy.
    Mohideen, P
    Klein, E
    Bruce, S
    DIABETOLOGIA, 2002, 45 : A242 - A242
  • [38] Improving Glycemic Control With Biphasic Insulin Aspart 30 in Chinese Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs: A Subgroup Analysis from the A1chieve Study
    Yang, Wenying
    Li, Yuxiu
    Chen, Liming
    Shi, Yongquan
    Peng, Yongde
    Lei, Minxiang
    DIABETES, 2012, 61 : A301 - A302
  • [39] Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study)
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Wang, Xueying
    Xu, Chun
    Bian, Fang
    Mu, Yiming
    DIABETES OBESITY & METABOLISM, 2017, 19 (11): : 1513 - 1520
  • [40] Phase III Study on Efficacy and Safety of Triple Combination (Exenatide/Metformin/Biphasic Insulin Aspart) Therapy for Type 2 Diabetes Mellitus
    Su, Ke
    Lv, Chunmei
    Ji, Zongwen
    Wang, Yishu
    Wang, Haifeng
    Bai, Ying
    Liu, Yaping
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (06) : E609 - E616
12345